New rabies vaccine enters first human safety tests
NCT ID NCT07338786
Summary
This is an early-stage safety study for a new freeze-dried version of a rabies vaccine. It will enroll 80 healthy volunteers aged 10-60 to test how safe the vaccine is when given on different schedules. The main goal is to monitor for any side effects in the 30 days after the final shot.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIESPREVENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jiangsu CDC
Xuzhou, Jiangsu, China
Conditions
Explore the condition pages connected to this study.